Gilead Sciences, Inc. et al v. Aurobindo Pharma Ltd. et al > Summary
Court Case Number 1:18-cv-00765
Filing Date May 18, 2018
Termination Date Oct 10, 2018
Court Delaware District Court
Status Dismissed - Settled
JudgesColm F. Connolly
Plaintiff Attorneys
8Gilead Sciences
Attorney Name: Brian E. Farnan
Farnan LLP
Gilead Sciences
Attorney Name: Michael J. Farnan
Farnan LLP
Emory University
Attorney Name: Brian E. Farnan
Farnan LLP
Emory University
Attorney Name: Michael J. Farnan
Farnan LLP
Gilead Sciences
Attorney Name: Christopher P. Borello
Venable
Gilead Sciences
Attorney Name: Frederick C. Millett
Venable
Emory University
Attorney Name: Christopher P. Borello
Venable
Emory University
Attorney Name: Frederick C. Millett
Venable
Defendant Attorneys
3Aurobindo Pharma
Attorney Name: Arthur G. Connolly III
Connolly Gallagher LLP
Aurobindo Pharma USA
Attorney Name: Arthur G. Connolly III
Connolly Gallagher LLP
Aurobindo Pharma USA
Attorney Name: Steven Jerome Moore
Withersworldwide
Counter Defendant
4Emory University
Attorney Name: Brian E. Farnan
Farnan LLP
Emory University
Attorney Name: Michael J. Farnan
Farnan LLP
Gilead Sciences
Attorney Name: Brian E. Farnan
Farnan LLP
Gilead Sciences
Attorney Name: Michael J. Farnan
Farnan LLP
Counter Claimant
2Aurobindo Pharma
Attorney Name: Arthur G. Connolly III
Connolly Gallagher LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 06703396 | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers | Mar 9, 2004 |
| 06642245 | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane | Nov 4, 2003 |
